Results 141 to 150 of about 10,985 (213)

Advancing Insights Into Visceral Leishmaniasis: Challenges, Innovations, and Future Directions in Global Disease Management. [PDF]

J Parasitol Res
Abbasi E.
europepmc   +1 more source

Drugs for 'neglected diseases': a bitter pill. [PDF]

, 2000
Pécoul, B, Veeken, H
core   +1 more source

Microbiological Profile of Meningoencephalitis Due to Pathogenic Free-Living Amoebae: A Case Series From Kerala, India. [PDF]

Cureus
Sankar P, Moorkoth AP, Khurana S, Mohan A, Vadekkandyil S, M SA, Vadakkayil B, Kumar P J, Rathor S, Govindan SKK.   +9 more
europepmc   +1 more source

Discovery of Cyclopentane-Based Phospholipids as Miltefosine Analogs with Superior Potency and Enhanced Selectivity Against <i>Naegleria fowleri</i>. [PDF]

Pharmaceuticals (Basel)
Hassan AHE, Lê HG, Võ TC, Kim M, No JH, Aboutaleb MH, Sim J, Na BK, Lee YS.   +8 more
europepmc   +1 more source

Drug susceptibility of a clinical isolate of <i>Balamuthia mandrillaris</i>, a pathogenic free-living amoeba. [PDF]

Antimicrob Agents Chemother
Dubey P, Kobpornchai P, Tongkrajang N, Chaiyaloom S, Lu C, Rice CA, Kulkeaw K.   +6 more
europepmc   +1 more source

Synthesis and Evaluation of a Hybrid Miltefosine-Silver Nanoparticle Complex: Synergistic Interaction with Benznidazole Against Trypanosoma cruzi. [PDF]

Acta Parasitol
Özel Y, Çavuş İ, Tokay F, Bağdat S, Özbilgin A.   +4 more
europepmc   +1 more source

Mitochondrial Dysfunction Induced by a Novel Salicylate-Based 1,2,3-Triazole Salt With Potent Antileishmanial Activity. [PDF]

Chem Biol Drug Des
De Oliveira BA, de Oliveira Lemos AS, Bastos JPRC, Antinarelli LMR, de Freitas ALR, Ribeiro RGM, da Silva Neto AF, Coimbra ES, Da Silva AD.   +8 more
europepmc   +1 more source

Tranylcypromine: a promising repurposed drug against Leishmaniases. [PDF]

Front Microbiol
Oualha R, Abdelkrim YZ, Essafi-Benkhadir K, Guizani I, Harigua-Souiai E.   +4 more
europepmc   +1 more source

Oral nanomedicines for the treatment of parasitic diseases [PDF]

, 2014
Dea Ayuela, Maria Auxiliadora, Lalatsa, Katerina, Serrano Lopez, Dolores Remedios, Smith, Lindsay   +3 more
core   +1 more source

<i>Entamoeba histolytica</i> "mutator" strain with a high rate of genetic mutations assists the elucidation of drug resistance mechanisms. [PDF]

Microbiol Spectr
Saito-Nakano Y, Izumiyama S, Hirai M, Kawano-Sugaya T, Jeelani G, Sardar SK, Ganguly S, Nozaki T.   +7 more
europepmc   +1 more source